169 related articles for article (PubMed ID: 10593003)
1. [The cost-effectiveness of hormonal replacement therapy].
Ylikorkala O
Duodecim; 1996; 112(12):1039-40. PubMed ID: 10593003
[No Abstract] [Full Text] [Related]
2. [The administration of hormonal replacement therapy].
Suhonen S
Duodecim; 1996; 112(12):1073-80. PubMed ID: 10593008
[No Abstract] [Full Text] [Related]
3. [Socioeconomic stakes of menopause: evaluation of the cost-effectiveness studies].
Plu-Bureau G; Bureau D; Thalabard JC
Rev Prat; 1993 Dec; 43(20):2665-9. PubMed ID: 8146568
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy: current concerns and considerations.
Carroll DG; Noble SL
Am J Manag Care; 2002 Jul; 8(7):663-75; quiz 676-8. PubMed ID: 12125806
[TBL] [Abstract][Full Text] [Related]
5. [Menopausal hormone replacement therapy and quality of life].
Salmi T
Duodecim; 1996; 112(12):1035-6. PubMed ID: 10593002
[No Abstract] [Full Text] [Related]
6. Hormone replacement therapy for my menopausal patients. Is it better to use oral or transdermal hormones?
Berliner S
Explore (NY); 2006 Mar; 2(2):184. PubMed ID: 16781635
[No Abstract] [Full Text] [Related]
7. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
Canonico M; Scarabin PY
Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
[No Abstract] [Full Text] [Related]
8. [Hormone replacement therapy--oral and transdermal administration].
Rozmus-Warcholińska W; Skrzypulec V; Drosdzol A; Nowosielski K; Piela B; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():259-61. PubMed ID: 15884252
[TBL] [Abstract][Full Text] [Related]
9. [Cost of hormonal replacement therapy in menopause].
Palacios Gil-Antuñano S
Rev Med Univ Navarra; 1991; 36(4):40-6. PubMed ID: 1821059
[No Abstract] [Full Text] [Related]
10. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
[TBL] [Abstract][Full Text] [Related]
11. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Shulman LP
J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
[No Abstract] [Full Text] [Related]
12. [Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico].
Velasco-Murillo V
Gac Med Mex; 2001; 137(3):237-42. PubMed ID: 11432092
[TBL] [Abstract][Full Text] [Related]
13. [A low dosage pile, until menopause, will facilitate medical practice.. Interview by Robert Henry].
Rioux JE
Union Med Can; 1993; 122(4):242-6. PubMed ID: 8367910
[No Abstract] [Full Text] [Related]
14. [Principles and overview of hormonal treatment of menopause].
Rozenbaum H
Soins Gynecol Obstet Pueric Pediatr; 1994 Feb; (153):7-11. PubMed ID: 8009392
[No Abstract] [Full Text] [Related]
15. [Estrogen replacement therapy in osteoporosis].
Hirvonen E
Duodecim; 1996; 112(22):2123-9. PubMed ID: 10605218
[No Abstract] [Full Text] [Related]
16. [Dermatoses caused by estrogens and progesterone: an upcoming nosology].
Estève E
Ann Dermatol Venereol; 1998 Aug; 125(8):484-5. PubMed ID: 9747310
[No Abstract] [Full Text] [Related]
17. The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.
Marque V; Alhenc-Gelas M; Plu-Bureau G; Oger E; Scarabin PY
Thromb Haemost; 2001 Aug; 86(2):713-4. PubMed ID: 11522028
[No Abstract] [Full Text] [Related]
18. [Replacement hormone therapy: the earlier the menopause, the greater the importance of treatment].
Fugère P
Union Med Can; 1992; 121(2):125-9. PubMed ID: 1570656
[No Abstract] [Full Text] [Related]
19. Use of menopausal hormones in the United States, 1992 through June, 2003.
Wysowski DK; Governale LA
Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
[TBL] [Abstract][Full Text] [Related]
20. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
